Abstract
Metabolism can convert drugs to harmful reactive metabolites that conjugate to DNA and off-target proteins. Reactive metabolites are a significant driver of both drug candidate attrition and withdrawal from the market of already approved drugs. Unfortunately, reactive metabolites are difficult to study in vivo, because they are transitory and generally do not circulate. Instead, this work computationally models both metabolism and reactivity. Using deep learning, predictive models were developed for the metabolic formation of quinones and epoxides, which together account for about half of known reactive metabolites. Additionally, an accurate model of DNA and protein reactivity was constructed, which predicts how likely a molecule is to be reactive, and therefore potentially toxic. To connect the metabolism and reactivity models, a system was developed for predicting the exact structures of quinones and epoxides. Finally, using the metabolite structure predictor as a stepping-stone, the quinone formation and epoxidation models were connected to the reactivity model to build an integrated bioactivation model of metabolism and reactivity.
Committee Chair
Sanjay J. Swamidass
Committee Members
Jeremy Buhler, Mark Anastasio, Gregory Bowman, Gary Stormo,
Degree
Doctor of Philosophy (PhD)
Author's Department
Biology & Biomedical Sciences (Computational & Systems Biology)
Document Type
Dissertation
Date of Award
Winter 12-15-2018
Language
English (en)
DOI
https://doi.org/10.7936/2x7h-bq64
Author's ORCID
http://orcid.org/0000-0001-6221-9014
Recommended Citation
Hughes, Tyler Brian, "Modeling the Bioactivation and Subsequent Reactivity of Drugs" (2018). Arts & Sciences Theses and Dissertations. 1687.
The definitive version is available at https://doi.org/10.7936/2x7h-bq64
Comments
Permanent URL: https://doi.org/10.7936/2x7h-bq64